CDK4 and neoplasm: There are many different potential explanations, including that CDK4/6 inhibition can induce senescence, apoptosis, metabolic reprogramming and/or anti‐tumour immunity (for reviews see (Goel et al, 2018; Klein et al, 2018)), but whether a common event underlies these different outcomes is unclear.